01 1Alembic Pharmaceuticals Limited
01 1DEFERASIROX
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-01-05
Pay. Date : 2016-07-19
DMF Number : 26833
Submission : 2013-02-27
Status : Active
Type : II
20
Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DEFERASIROX, with a corresponding US DMF Number 26833.
Remarkably, this DMF maintains an Active status since its submission on February 27, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 05, 2017, and payment made on July 19, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
